We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002670:SZSEGuosheng Securities Inc. Class A Analysis

Data as of 2026-03-12 - not real-time

CN¥15.78

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Guosheng Securities is trading at a trailing P/E of roughly 93, dramatically above the industry average of 16.6, while its DCF‑derived fair value sits near 14.7 CNY—well under the current price of 15.78 CNY. The stock is below its 200‑day SMA (16.93) and the computed trend is bearish, yet the MACD histogram is modestly positive, giving a bullish signal on a short‑term basis. Support is identified around 15.30 CNY with resistance near 17.32 CNY, and volume has remained stable, suggesting limited immediate buying pressure. Balance‑sheet metrics reveal a high debt‑to‑equity ratio of over 158% despite a sizable cash buffer of 23.9 bn CNY, which mitigates liquidity concerns but underscores financial risk. Profitability is weak, with ROE under 3% and operating margins around 22%, and the company does not pay a dividend. Market sentiment is in an "Extreme Greed" phase, reflected by a Fear & Greed index of 75.6, which could be inflating the price further. Overall, the combination of severe overvaluation, modest technical upside, high leverage, and low earnings growth points to a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near technical support at 15.30 CNY
  • Bearish longer‑term trend despite bullish MACD
  • Overvaluation relative to earnings and DCF

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Trailing P/E far above industry norm
  • High debt‑to‑equity ratio stressing balance sheet
  • Weak ROE and profit margins limiting growth

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Large cash reserves provide a cushion
  • Potential for price correction toward DCF fair value
  • Limited dividend yield and low earnings growth

Key Metrics & Analysis

Financial Health

Revenue Growth108.00%
Profit Margin15.16%
P/E Ratio92.8
ROE2.93%
ROA0.71%
Debt/Equity158.60
P/B Ratio2.7
Op. Cash FlowCN¥846.5M
Industry P/E16.6

Technical Analysis

TrendBearish
RSI43.7
SupportCN¥15.30
ResistanceCN¥17.32
MA 20CN¥16.02
MA 50CN¥16.47
MA 200CN¥16.93
MACDBullish
VolumeStable
Fear & Greed Index75.63

Valuation

Fair ValueCN¥14.71
GradeOvervalued
TypeValue

Risk Assessment

Beta0.15
Volatility24.12%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.